Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy

Table 1 Clinical characteristics, n

	Transplant patients	HD patients	General population
Total	120	231	450
Sex (male:female)	82:38	126:105	178:272
Median age (yr)	48	63	40
Causes of renal failure	Chronic glomerulonephritis: 43	Chronic glomerulonephritis: 73
	Nephroangiosclerosis: 21	Nephroangiosclerosis: 27
	Polycystic kidney disease: 16	Polycystic kidney disease: 32
	Diabetic nephropathy: 14	Diabetic nephropathy: 44
	Chronic interstitial nephritis: 11	Chronic interstitial nephritis: 26
	Other aetiologies: 15	Other aetiologies: 29
Median HD treatment	18 mo (range: 1-54 mo)	79 mo (range: 3-154 mo)
	17 mo (range: 1-48 mo) HEV-negative	78.9 mo (range: 3-149 mo) HEV-negative
	21 mo (range: 3-54 mo) HEV-positive	81 mo (range: 7-154 mo) HEV-positive
Immunosuppressive treatment	All of the patients (120)	Yes: 2 (males)

HEV: Hepatitis E virus; HD: Hemodialysis.

Table 2 Hepatitis E virus antibodies n (%)

	Transplant patients	HD patients	General population
Total	120	231	450
Anti-HEV Ig pos.	4 (3.3)	14 (6)	12 (2.7)
HEV IgM pos.	1	2	1
HEV RNA pos.	2	3	1

HEV: Hepatitis E virus; HD: Hemodialysis.